UCB announced that it has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule,...
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...
Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva® CTD Essential Reagent for use...
AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched...
Rousselot, Darling Ingredients' health brand, and the global leader of collagen-based solutions1, announces that the European Patent Office (EPO) has granted the company's patent...
